COA

Latest from COA


Oncology Practices Shift to Telemedicine to Combat COVID-19

March 31, 2020

COA conducted a webinar on the impact of COVID-19 on oncology practices and introduced several experts across the nation to share how their institutions have adjusted during this time to accommodate patients.

COA President Urges White House to Waive Prior Authorization Requirements for Cancer Treatment

March 24, 2020

In an open letter to the President of the United States, the Community Oncology Alliance brings attention to the critical needs of patients with cancer. Community Oncology Alliance requests all private health insurance companies immediately waive all “prior authorization” requirements for cancer treatments, which pose threat to cancer treatment, particularly in patients who are elderly and among the most vulnerable in the United States to contract COVID-19.

Patient Misconceptions About Clinical Trials Are a Common Source of Resistance, Expert Panel Says

April 08, 2019

Before a community oncology practice considers getting involved in clinical trials research, there are many factorsto consider. Perhaps foremost is the fact that cancer clinical trials provide the evidence base for new advances in oncology.

Despite Slow Adoption, Artificial Intelligence Pilot Programs Yield Practical Results

April 06, 2019

Artificial intelligence has made inroads in many industries—banking, finance, security—but its adoption in healthcare has been lagging and real-world clinical implementation has yet to become a reality. Nonetheless, proponents say it is only a matter of time and pilot programs are starting to yield some practical results.